Patent details

93180 Product Name: "Alirocumab ou un dérivé pharmaceutiquement acceptable de celui-ci (PRALUENT)"

Basic Information

Publication number:
93180
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP087985503
Legal Status:
Inactive
Application number:
93180
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1031
Marketing Authorization Type:
Marketing Authorization Date:
25/09/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
18/08/2016
First Marketing Authorization date:
25/09/2015
Grant date:
18/10/2016
Activation date:
Publication date:
18/10/2016
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
25/09/2030
SPC Extension Expiration:
25/09/2030
Rejection date:
Withdrawal date:

Owner

From:
18/08/2016
 
 

Name:
AMGEN INC.
Address:
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA 91320-1799, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/08/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WALKER Nigel Pelham, Clinton
Address:
United States (US)

2

Name:
MEHLIN Christopher
Address:
United States (US)

3

Name:
PIPER Derek, Evan
Address:
United States (US)

4

Name:
SHAN Bei
Address:
United States (US)

5

Name:
KING Chadwick, Terence
Address:
Canada (CA)

6

Name:
KETCHEM Randal, Robert
Address:
United States (US)

7

Name:
CHAN Joyce Chi, Yee
Address:
United States (US)

8

Name:
CAO Qiong
Address:
United States (US)

9

Name:
JACKSON Simon, Mark
Address:
United States (US)

10

Name:
SHEN Wenyan
Address:
United States (US)

11

Name:
CARABEO Teresa, Arazas
Address:
United States (US)

Annual Fees

Annual Fee Due Date:
31/08/2028
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
23/08/2016 Incoming Correspondence (Post) 2